Table 1.
Baseline clinical characteristics and exercise data.
| Variable | All Patients (n = 862) | Patients with AE a (n = 87, 10.1%) | Patients without AE a (n = 775, 89.9%) | p Value |
|---|---|---|---|---|
| Male gender | 364 (42.2%) | 56 (64.4%) | 308 (39.7%) | <0.001 |
| Age (years) | 56 ± 10 | 60 ± 10 | 55 ± 10 | <0.001 |
| Hypertension | 603 (70%) | 67 (77%) | 536 (69.2%) | 0.130 |
| Hyperlypoproteinemia | 488 (56.6%) | 50 (57.5%) | 438 (56.5%) | 0.865 |
| Smoker | 326 (37.9%) | 38 (44.2%) | 288 (37.2%) | 0.203 |
| Diabetes | 118 (13.7%) | 24 (27.6%) | 94 (12.1%) | <0.001 |
| Family history of CAD b | 509 (59%) | 49 (56.3%) | 460 (59.4%) | 0.585 |
| Typical chest pain | 403 (48.4%) | 71 (81.6%) | 498 (64.3%) | 0.001 |
| Duration of the test (minutes) | 7.4 ± 2.7 | 7.0 ± 2.7 | 7.5 ± 2.8 | 0.132 |
| Chronotropic index < 0.8 | 411 (47.7%) | 54 (62.1%) | 364 (47%) | 0.008 |
| Achieved target heart rate | 674 (78.2%) | 62 (71.3%) | 612 (79%) | 0.099 |
| Maximum achieved SBP c (mmHg) | 180 ± 21 | 183 ± 21 | 179 ± 22 | 0.126 |
| Maximum achieved DBP d (mmHg) | 100 ± 11 | 100 ± 11 | 100 ± 11 | 0.946 |
| Slow HRR e | 45 (5.2%) | 11 (12.6%) | 34 (4.4%) | 0.001 |
a AEs—adverse events (death + myocardial infarction + CABG + PCI), b CAD—coronary artery disease, c SBP—systolic blood pressure, d DBP—diastolic blood pressure, e HRR—heart rate recovery.